Media 26 May 2021 Orthocell (ASX:OCC) granted new patents for ACL repair treatment Orthocell has been featured in The Market Herald, following our announcement of granted patents in China and Hong Kong for… Orthocell
Media 15 Feb 2021 Orthocell (ASX:OCC) receives new U.S. patent for CelGro Orthocell has been featured in The Market Herald, following the announcement of a newly granted U.S. divisional patent for CelGro.… Orthocell
Media 14 Jan 2021 Orthocell’s stock soars following FDA 510(k) clearance of regenerative collagen medical device BioWorld has reported on Orthocell's rising share price, following the U.S. approval for our collagen medical device for dental guided… Orthocell
Media 09 Jan 2021 UWA invention to speed up healing in dental patients Orthocell's Striate+™ has been featured in Bite Magazine, highlighting its effectiveness for dental bone defect repair and tissue augmentation around… Orthocell
Video 06 Jan 2021 Australia’s TGA approves Orthocell’s Celgro™ regenerative collagen medical device Orthocell CEO Paul Anderson spoke to BioWorld, following marketing clearance from Australia’s Therapeutic Goods Administration (TGA) for our Celgro™ collagen… Orthocell
Media 20 Nov 2020 Medical miracle brings limbs back to life The incredible story of Adrian Walsh, featuring Orthocell's CelGro™ nerve treatment, has been featured in the Weekend Australian. Orthocell
Video 10 Nov 2020 HCP Webinar | Latest Developments in the Biological Treatment of Cartilage – Professor Martin Sullivan Professor Martin Sullivan Foot and Ankle Surgeon at St. Vincent’s Clinic & North Shore Private Hospital in Sydney presents 'An… Orthocell
Media, Video 22 Sep 2020 Video | Proactive Investors Interview – September 2020 Orthocell CEO and Managing Director Paul Anderson spoke with Andrew Scott from Proactive Investors about the company being in an… Orthocell
Video 22 May 2020 Australia’s Orthocell submits 510(k) for Celgro™ regenerative collagen medical device Orthocell has been featured in BioWorld, following the submission of a 510(k) application to the U.S. FDA for our Celgro™… Orthocell
Video 11 Mar 2020 Orthocell looks to enter US market following positive CelGro™ study results Small Caps has featured Orthocell's plans to enter the US market following the success of our Celgro™ dental implant study. Orthocell
